Israeli oncologists lead international clinical trials for stage 4 colon cancer, providing access to experimental immunotherapies and targeted combinations. Specialists like Dr. Einat Shacham Shmueli at Sheba Medical Center serve as investigators for major research programs, including the NCI and RTOG, to improve results for metastatic disease.
- Investigative leadership. Dr. Einat Shacham Shmueli investigates international oncology research programs for gastrointestinal cancers.
- Molecular research. Professor Raanan Berger at Sheba leads clinical research focusing on molecular oncology pathways.
- Translational medicine. Dr. Yaacov Lawrence directs the Center for Translational Radiation Oncology, merging research with care.
- Microbiome innovation. Professor Beni Boursi researches microbial modulation to enhance the effectiveness of cancer therapies.
Bookimed Expert Insight: Patients seeking clinical trials should prioritize centers like Sheba Medical Center, where senior leaders also head research units. Data shows these specialists, such as Professor Raanan Berger, often lead the very departments that manage trial registries. This dual role frequently provides patients with faster access to emerging protocols for complex colorectal malignancies.
Patient Consensus: Patients found that booking a second opinion at a major cancer center was the most effective way to identify available trials. They recommend discussing trial matching early in the journey while planning treatment for stage 4 disease.